Immediate-release Indiplon (a non-benzodiazepine GABA-A receptor agonist; works for about 3-4 hours) is well tolerated and effective in helping patients treated for chronic insomnia, according to a presentation given at the 157th annual meeting of the American Psychiatric Association (APA).